US health experts spoke on social media and other platforms on Friday and Saturday to welcome the possibility that federal regulators will soon offer boosters for Pfizer-BioNTech to those 65 years of age or older or with severe COVID-19. at higher risk, although some argue that the age limit should be lower.
Experts on Friday responded to the actions of the Food and Drug Administration Advisory Committee. The agency’s recommendation to allow refresher courses related to refusal to transition to general licensure for everyone over the age of 16.
The only vaccine against COVID-19 for which the FDA has sufficient information to determine the effectiveness of the booster is made by Pfizer-BioNtech. The timing of the other two vaccines used in the US, Moderna and Johnson & Johnson, is questionable.
But dr. Ja also tweeted that the booster would be useful for people aged 60 and over.
dr. Eric Topol, Professor of Molecular Medicine at Scripps Research in La Jolla, California, described the FDA committee’s decision as “an excellent result”. The decision, he wrote on Twitter, acknowledged “the need for people at high risk due to comorbidities or occupational risks, such as health workers, key workers and teachers.”
However, Topol also questioned that the endpoint for third inclusion eligibility was 65. He also said the updated FDA recommendations “do not address the vulnerability of those who receive J&J photos”.
dr. Paul Ofit, a vaccine specialist at Children’s Hospital of Philadelphia, told the Associated Press that he supports a third dose for parents, but “I don’t care” when it comes to failing at the idea of shooting every shot. “I’m in trouble.”
To some Americans outside the medical or scientific field, the recommendations of the FDA commission seem opaque or even contradictory.
For example, Jane Massey, a floral designer for weddings and events in Orange County, California, wrote on Twitter discussing what she thought was a pressing issue with a reporter for the Times: “Can you explain why boosters are for people at high risk? , although the general population requires further testing. “Do you have to wait? That doesn’t make sense.”
Michael Knowles, a conservative media personality with a large following on social media and via The Daily Wire, a website that publishes commentary and podcasts, saw the FDA panel’s actions humorously. “The vaccine is so effective that you need a booster shot and so safe that the FDA won’t approve a booster,” he wrote on Twitter. “Am I right?”
Read more articles